Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Predictive Oncology ROE 2010-2025 | POAI

Current and historical return on equity (ROE) values for Predictive Oncology (POAI) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
  
Predictive Oncology ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-03-31 $-0.01B $0.00B -666.67%
2024-12-31 $-0.01B $0.00B -480.00%
2024-09-30 $-0.01B $0.00B -288.89%
2024-06-30 $-0.01B $0.00B -185.71%
2024-03-31 $-0.01B $0.00B -143.59%
2023-12-31 $-0.01B $0.01B -96.30%
2023-09-30 $-0.02B $0.01B -105.88%
2023-06-30 $-0.02B $0.02B -88.37%
2023-03-31 $-0.03B $0.02B -95.24%
2022-12-31 $-0.03B $0.02B -81.30%
2022-09-30 $-0.03B $0.03B -70.92%
2022-06-30 $-0.03B $0.03B -65.41%
2022-03-31 $-0.02B $0.04B -42.70%
2021-12-31 $-0.02B $0.04B -45.20%
2021-09-30 $-0.02B $0.05B -65.71%
2021-06-30 $-0.03B $0.05B -96.15%
2021-03-31 $-0.03B $0.04B -165.08%
2020-12-31 $-0.03B $0.00B -291.89%
2020-09-30 $-0.03B $0.01B -266.67%
2020-06-30 $-0.03B $0.01B -200.00%
2020-03-31 $-0.02B $0.01B -137.50%
2019-12-31 $-0.02B $0.01B -148.15%
2019-09-30 $-0.01B $0.02B -83.72%
2019-06-30 $-0.01B $0.02B -128.00%
2019-03-31 $-0.01B $0.00B -733.33%
2018-12-31 $-0.01B $0.00B -363.64%
2018-09-30 $-0.01B $0.00B -228.57%
2018-06-30 $-0.01B $0.00B -184.62%
2018-03-31 $-0.01B $0.01B -215.38%
2017-12-31 $-0.01B $0.00B -200.00%
2017-09-30 $-0.01B $0.00B -240.00%
2017-06-30 $-0.01B $0.00B -300.00%
2017-03-31 $-0.01B $0.00B -400.00%
2016-12-31 $-0.01B $0.00B -560.00%
2016-09-30 $-0.01B $0.00B -400.00%
2016-06-30 $-0.01B $0.00B -228.57%
2016-03-31 $-0.01B $0.00B -342.86%
2015-12-31 $0.00B $0.00B 800.00%
2015-09-30 $0.00B $0.01B 133.33%
2015-06-30 $0.00B $-0.01B 72.73%
2015-03-31 $-0.01B $-0.01B 105.26%
2014-12-31 $-0.01B $-0.01B 186.67%
2014-09-30 $-0.01B $0.00B 233.33%
2014-06-30 $-0.01B $0.00B 444.44%
2014-03-31 $-0.01B $0.00B 400.00%
2013-12-31 $-0.01B $0.00B 360.00%
2013-09-30 $-0.01B $0.00B 360.00%
2013-06-30 $-0.01B $0.00B 290.91%
2013-03-31 $-0.01B $0.00B 360.00%
2012-12-31 $-0.01B $0.00B 320.00%
2012-09-30 $-0.01B $0.00B 360.00%
2012-06-30 $-0.01B $0.00B 280.00%
2012-03-31 $-0.01B $0.00B 200.00%
2011-12-31 $0.00B $0.00B 177.78%
2011-09-30 $0.00B $0.00B 50.00%
2011-06-30 $0.00B $0.00B 0.00%
2011-03-31 $0.00B $0.00B 0.00%
2010-12-31 $0.00B $0.00B 50.00%
2010-09-30 $0.00B $0.00B 50.00%
2010-06-30 $0.00B $0.00B 100.00%
2010-03-31 $0.00B $0.00B 200.00%
2009-12-31 $0.00B $0.00B 300.00%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.008B $0.002B
Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.989B 58.51
Hims & Hers Health (HIMS) United States $13.669B 142.02
Tempus AI (TEM) United States $11.962B 0.00
IRhythm Technologies (IRTC) United States $4.646B 0.00
Inspire Medical Systems (INSP) United States $3.825B 59.77
Hinge Health (HNGE) United States $3.100B 0.00
Privia Health (PRVA) United States $2.659B 181.75
Enovis (ENOV) United States $1.751B 9.76
Schrodinger (SDGR) United States $1.545B 0.00
Phreesia (PHR) United States $1.527B 0.00
Clover Health Investments (CLOV) United States $1.511B 0.00
Azenta (AZTA) United States $1.371B 63.70
10x Genomics (TXG) United States $1.338B 0.00
Omnicell (OMCL) United States $1.324B 23.36
Claritev (CTEV) United States $0.663B 0.00
Fulgent Genetics (FLGT) United States $0.618B 0.00
Butterfly Network (BFLY) United States $0.534B 0.00
Veradigm (MDRX) United States $0.482B 0.00
Talkspace (TALK) United States $0.463B 138.50
Standard BioTools (LAB) United States $0.414B 0.00
Outset Medical (OM) United States $0.347B 0.00
TruBridge (TBRG) United States $0.346B 766.67
Nyxoah SA (NYXH) Belgium $0.263B 0.00
Health Catalyst (HCAT) United States $0.254B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.203B 0.00
KORU Medical Systems (KRMD) United States $0.150B 0.00
EUDA Health Holdings (EUDA) Singapore $0.139B 0.00
Pulmonx (LUNG) United States $0.111B 0.00
CareCloud (CCLD) United States $0.107B 4.06
American Well (AMWL) United States $0.106B 0.00
MDxHealth SA (MDXH) Belgium $0.096B 0.00
111 (YI) China $0.068B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.046B 0.00
P3 Health Partners (PIII) United States $0.045B 0.00
Zepp Health (ZEPP) Netherlands $0.035B 0.00
Zhongchao (ZCMD) China $0.031B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Movano (MOVE) United States $0.005B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.001B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00